Chemotherapy-induced anemia: etiology, pathophysiology, and implications for contemporary practice
Emily Bryer, David Henry Internal Medicine, Pennsylvania Hospital, University of Pennsylvania Health System, Philadelphia, PA, USA Abstract: Chemotherapy-induced anemia (CIA) is a multifaceted entity influenced by a variety of patient- and treatment-specific factors. Some sources of variation within...
Main Authors: | Bryer E, Henry D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-11-01
|
Series: | International Journal of Clinical Transfusion Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/chemotherapy-induced-anemia-etiology-pathophysiology-and-implications--peer-reviewed-article-IJCTM |
Similar Items
-
Assessment of chemotherapy-induced anemia in children with cancer
by: Ruggiero Antonio, et al.
Published: (2008-09-01) -
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials
by: Renata Ferrarotto, et al.
Published: (2021-09-01) -
Anemias in Oncology: Potential of Maintenance Therapy
by: AV Snegovoi, et al.
Published: (2016-07-01) -
Management and prevention of anemia (acute bleeding excluded) in adult critical care patients
by: Sigismond Lasocki, et al.
Published: (2020-07-01) -
Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
by: N. A. Romanenko, et al.
Published: (2014-07-01)